Bapineuzumab and solanezumab for Alzheimer's disease: is the ‘amyloid cascade hypothesis' still alive?
出版年份 2013 全文链接
标题
Bapineuzumab and solanezumab for Alzheimer's disease: is the ‘amyloid cascade hypothesis' still alive?
作者
关键词
-
出版物
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 13, Issue 7, Pages 1075-1084
出版商
Informa Healthcare
发表日期
2013-04-11
DOI
10.1517/14712598.2013.789856
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Midlife Coffee and Tea Drinking and the Risk of Late-Life Dementia: A Population-Based CAIDE Study
- (2017) Marjo H. Eskelinen et al. JOURNAL OF ALZHEIMERS DISEASE
- Type 2 Diabetes Mellitus, Dyslipidemia, and Alzheimer's Disease
- (2017) Cynthia M. Carlsson JOURNAL OF ALZHEIMERS DISEASE
- Safety and biomarker effects of solanezumab in patients with Alzheimer’s disease
- (2012) Martin Farlow et al. Alzheimers & Dementia
- 2011 Alzheimer’s disease facts and figures
- (2011) Alzheimers & Dementia
- Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- Tramiprosate in mild-to-moderate Alzheimer’s disease – a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)
- (2011) Paul S. Aisen et al. Archives of Medical Science
- Amyloid-Dependent and Amyloid-Independent Stages of Alzheimer Disease
- (2011) Bradley T. Hyman ARCHIVES OF NEUROLOGY
- Monoclonal antibodies against β-amyloid (Aβ) for the treatment of Alzheimer's disease: the Aβ target at a crossroads
- (2011) Francesco Panza et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Solanezumab for Alzheimer's disease
- (2011) Hossein Samadi et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Pharmacotherapies for Alzheimer's disease: Beyond cholinesterase inhibitors
- (2011) Haythum O. Tayeb et al. PHARMACOLOGY & THERAPEUTICS
- A Single Ascending Dose Study of Bapineuzumab in Patients With Alzheimer Disease
- (2010) Ronald S. Black et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Alzheimer’s Prevention Initiative: a proposal to evaluate presymptomatic treatments as quickly as possible
- (2010) Eric M Reiman et al. Biomarkers in Medicine
- Safety and Changes in Plasma and Cerebrospinal Fluid Amyloid β After a Single Administration of an Amyloid β Monoclonal Antibody in Subjects With Alzheimer Disease
- (2010) Eric R. Siemers et al. CLINICAL NEUROPHARMACOLOGY
- Healthy Brain Aging: Effect of Head Injury, Alcohol and Environmental Toxins
- (2010) Vikas Kumar et al. CLINICS IN GERIATRIC MEDICINE
- Bapineuzumab: anti-β-amyloid monoclonal antibodies for the treatment of Alzheimer’s disease
- (2010) Francesco Panza et al. Immunotherapy
- Traumatic brain injury and amyloid-β pathology: a link to Alzheimer's disease?
- (2010) Victoria E. Johnson et al. NATURE REVIEWS NEUROSCIENCE
- Mild cognitive impairment and on to dementia: Down the slippery slope but faster
- (2010) D. S. Knopman NEUROLOGY
- Role of Infection in the Pathogenesis of Alzheimerʼs Disease
- (2009) Clive Holmes et al. CNS DRUGS
- Uncontrolled diabetes increases the risk of Alzheimer’s disease: a population-based cohort study
- (2009) W. L. Xu et al. DIABETOLOGIA
- Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer DiseaseA Randomized Controlled Trial
- (2009) Robert C. Green JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Begacestat (GSI-953): A Novel, Selective Thiophene Sulfonamide Inhibitor of Amyloid Precursor Protein -Secretase for the Treatment of Alzheimer's Disease
- (2009) R. L. Martone et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- MRI and CSF biomarkers in normal, MCI, and AD subjects: Predicting future clinical change
- (2009) P. Vemuri et al. NEUROLOGY
- A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
- (2009) S. Salloway et al. NEUROLOGY
- Lack of Evidence for Borrelia burgdorferi Seropositivity in Alzheimer Disease
- (2008) Alessio Galbussera et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Current approaches in the treatment of Alzheimer's disease
- (2008) Reena S. Shah et al. BIOMEDICINE & PHARMACOTHERAPY
- Vascular risk factors and Alzheimer’s disease
- (2008) David F Cechetto et al. Expert Review of Neurotherapeutics
- Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses
- (2008) Lars Bertram et al. NATURE REVIEWS NEUROSCIENCE
- Antibody Capture of Soluble Aβ Does Not Reduce Cortical Aβ Amyloidosis in the PDAPP Mouse
- (2008) Peter Seubert et al. Neurodegenerative Diseases
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started